This paper will review the pathophysiology and treatment of decompensated HF, with a special focus on the recombinant form of human BNP (i.e., nesiritide).
Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated heart failure (ADHF) and is associated with poor clinical outcome. The pathophysiology of CRS entails a complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback